Early use of corticosteroids in non-critical patients with COVID-19 pneumonia (PREDCOVID): a structured summary of a study protocol for a randomised controlled trial
Abstract Objectives To evaluate the efficacy of early treatment with prednisone to decrease the progression of COVID-19 pneumonia. Trial design This is a pragmatic, non-blinded, randomized, two arms, parallel trial. Participants Patients between 18 and 90 years, with COVID-19 pneumonia, confirmed by...
Main Authors: | Mauricio Salinas, Paulette Andino, Leonor Palma, Javiera Valencia, Elizabeth Figueroa, Jhonatan Ortega |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-021-05046-6 |
Similar Items
-
Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial
by: Miriam Saiz-Rodríguez, et al.
Published: (2020-07-01) -
Heterogeneity in pragmatic randomised trials: sources and management
by: Bruno Giraudeau, et al.
Published: (2022-10-01) -
The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization
by: David T. Huang, et al.
Published: (2021-05-01) -
Undertaking a randomised controlled trial in the police setting: methodological and practical challenges
by: Arabella Scantlebury, et al.
Published: (2017-12-01) -
Extended data - Appendices - A randomised controlled trial of tamoxifen for cryptococcal meningitis
by: Day, J
Published: (2019)